Clinical trials
Enrolling by invitation Phase 1/2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Chest Hospital | 2 |
| Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 1 |
| Capital Medical University | 1 |
| Chinese PLA General Hospital | 1 |
| Fujian Medical University | 1 |
| Guangzhou Jiayin Biotech Ltd | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Jiujiang No.1 People's Hospital | 1 |
| Man Hu | 1 |
| Peking Union Medical College Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 2 |
| Tuberculosis | 2 |
| Adenoviridae Infections | 1 |
| Anemia, Aplastic | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Glioblastoma | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.